ARTICLE | Company News
Geron, Kyowa Hakko Kogyo Co. Ltd. deal
July 5, 2004 7:00 AM UTC
Kyowa will return Asian rights to GERN's telomerase inhibitors, which Kyowa gained under a 1995 deal. The inhibitors are in preclinical development to treat cancer. Kyowa said it made the decision be...